Holen Sie sich die Stockscreener-App
10.86
0.55%
-0.06
Handel nachbörslich:
10.86
Schlusskurs vom Vortag:
$10.92
Offen:
$10.96
24-Stunden-Volumen:
224.32K
Relative Volume:
0.68
Marktkapitalisierung:
$576.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-6.7453
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
+6.05%
1M Leistung:
+13.24%
6M Leistung:
-32.92%
1J Leistung:
-45.97%
1-Tages-Spanne:
$10.82
$11.31
1-Wochen-Bereich:
$9.965
$11.31
52-Wochen-Spanne:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.86 | 544.54M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Tyra Biosciences Rises On Precision Medicine Hopes And Analyst Support - Finimize
What makes Tyra Biosciences Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Why Tyra Biosciences Inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
How Tyra Biosciences Inc. stock performs during market volatilityFree Capital Growth Strategies - Newser
Tyra Biosciences Insider Lowered Holding By 58% During Last Year - simplywall.st
Advanced Urothelial Carcinoma Clinical Trials 2025: EMA, PDMA, - openPR.com
Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025 - Eastern Progress
Tyra Biosciences' TYRA-300 Emerges as Dual-Threat Therapy, Poised to Drive Clinical and Market Momentum - AInvest
New TYRA-300 Preclinical Data Reveals Promising Results for Rare Bone Growth Disorder Treatment - Stock Titan
Where are the Opportunities in (TYRA) - news.stocktradersdaily.com
Tyra Biosciences’ (TYRA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
TYRA-300 Begins Phase 2 Trial in FGFR3-Altered NMIBC - Targeted Oncology
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302) - Longview News-Journal
Tyra Biosciences, Inc.(NasdaqGS: TYRA) added to Russell 2000 Value Index - MarketScreener
Revolutionary Oral Treatment for Bladder Cancer Begins Phase 2 Trial: First Patient Receives TYRA-300 - Stock Titan
When the Price of (TYRA) Talks, People Listen - news.stocktradersdaily.com
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
California State Teachers Retirement System Sells 2,366 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 10,426 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
RA Capital Boosts Stake in Tyra Biosciences (TYRA) to 22.4% | TYRA Stock News - GuruFocus
Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail
June Brings on Some Huge Insider Buying - 24/7 Wall St.
Kernaghan buying at Western Forest Products (WEF) - The Globe and Mail
Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews
Two Sigma Investments LP Has $643,000 Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences Soars 10.71% on Insider Buying - AInvest
Two Sigma Investments LP Grows Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Jane Street Group LLC Acquires Shares of 26,297 Skillz Inc. (NYSE:SKLZ) - Defense World
Schwab International Equity ETF (NYSEARCA:SCHF) Shares Sold by Squarepoint Ops LLC - Defense World
Zumiez Inc. (NASDAQ:ZUMZ) Shares Sold by Two Sigma Investments LP - Defense World
Squarepoint Ops LLC Invests $253,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Two Sigma Advisers LP Purchases 92,800 Shares of ThredUp Inc. (NASDAQ:TDUP) - Defense World
Two Sigma Advisers LP Takes $162,000 Position in Innovex International, Inc. (NYSE:INVX) - Defense World
Two Sigma Advisers LP Makes New $171,000 Investment in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Bank of America Corp DE Purchases 11,804 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Klondike Silver (CVE:KS) Trading Up 50% – What’s Next? - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Rating of “Buy” from Analysts - Defense World
Wishbone Gold (LON:WSBN) Trading 21.6% Higher – Should You Buy? - Defense World
AGM Group (NASDAQ:AGMH) Rating Increased to Hold at Wall Street Zen - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of “Buy” from Analysts - Defense World
BlackRock MuniYield Michigan Quality Fund, Inc. (NYSE:MIY) Short Interest Up 21.4% in May - Defense World
Motorcar Parts of America, Inc. (NASDAQ:MPAA) Shares Sold by Two Sigma Advisers LP - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
PortfolioPlus S&P 500 ETF (NYSEARCA:PPLC) Shares Up 2.2% – What’s Next? - Defense World
BNP Paribas Financial Markets Purchases New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Deutsche Bank AG Acquires 6,466 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Millennium Management LLC Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Bioscience Holds 2025 Annual Stockholders Meeting - TipRanks
TYRA Stock: Upcoming Oppenheimer Meeting Announcement | TYRA Sto - GuruFocus
Bank of America Corp DE Sells 1,164,431 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) - Defense World
Trading (TYRA) With Integrated Risk Controls - news.stocktradersdaily.com
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):